Menu Search
Equities

Bluelinea SA

ALBLU:PAR

Bluelinea SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.93
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change-26.19%
  • Beta0.4201
Data delayed at least 15 minutes, as of Nov 14 2024 08:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Bluelinea SA's revenues fell -5.59% from 10.41m to 9.83m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.54m to a larger loss of 1.62m.
Gross margin103.22%
Net profit margin-17.72%
Operating margin-17.69%
Return on assets-15.28%
Return on equity-73.14%
Return on investment-37.21%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Bluelinea SA fell by 3.56m. Cash Flow from Financing totalled 22.83k or 0.23% of revenues. In addition the company used 644.38k for operations while cash used for investing totalled 2.94m.
Cash flow per share0.0147
Price/Cash flow per share63.13
Book value per share0.1189
Tangible book value per share-0.3169
More ▼

Balance sheet in EURView more

Bluelinea SA has a Debt to Total Capital ratio of 75.59%, a higher figure than the previous year's 55.62%.
Current ratio0.4874
Quick ratio0.4416
Total debt/total equity3.10
Total debt/total capital0.7559
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.